During the past decade, Front Range ENT conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Front Range ENT" are "Chronic Sinus Infection" (1 trials) and "Ethmoid Sinusitis" (1 trials). Many other conditions were trialed in "Front Range ENT" in a lesser frequency.

Most popular intervention types in "Front Range ENT" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sinopsys Lacrimal Stent" (1 trials) and "Sinopsys® Lacrimal Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Front Range ENT" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Front Range ENT". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Front Range ENT, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Front Range ENT, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".